A Phase 3 interventional study of Rocuronium bolus maintenance and rocuronium continuous infusion maintenance in Anesthesia, sponsored by Merck Sharp & Dohme LLC. Completed. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2016-08-24.
Sponsored by Merck Sharp & Dohme LLC (part of Merck & Co., Inc) · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary purpose of this study is to determine the dose requirements of rocuronium bromide when administered as a bolus dose (a single, large dose) for intubation (insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation) and when administered by either continuous infusion or bolus doses for maintenance of muscle relaxation in term neonates (birth to \<28 days old), infants (28 days to \<=3 months) and toddlers (>3 months to \<=2 years), children (2 years to less than or equal to 11 years of age), and adolescents (>11 years to less than or equal to 17 years of age).
Merck Sharp & Dohme LLC is the lead sponsor of 2,167 studies on the registry; 132 are open to participants now.
Of its 503 completed or terminated interventional studies of FDA-regulated products, 371 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Rocuronium bolus maintenance
Drug: Rocuronium bolus maintenance
Rocuronium continuous infusion maintenance
Drug: rocuronium continuous infusion maintenance
Subjects received a bolus dose of rocuronium for intubation followed by bolus doses for maintenance of muscle relaxation
Also known as: Zemuron, ORG 9426
Subjects received a bolus dose of rocuronium for intubation followed by continuous infusion of rocuronium for maintenance of muscle relaxation
Also known as: Zemuron, ORG 9426
Total Dose of Zemuron (Rocuronium) Administered
Total dose from administration of intubating dose to reappearance of T3 (the third twitch of a Train of Four \[TOF\] stimulation) after the last maintenance bolus dose or discontinuation of Zemuron (rocuronium) infusion (Per protocol \[PP\] data set)
Time frame: during surgery
Duration of Recovery of T4/T1 Ratio (TOF Fourth Twitch to First Twitch) 70%
The time it takes for the the T4 to T1 ratio to reach 70%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
Time frame: after surgery, from the reappearance of T3 after Zemuron(R) (rocuronium) infusion/last bolus dose of Zemuron(R) (rocuronium)
Duration of Recovery of T4/T1 (TOF Fourth Twitch to First Twitch) Ratio 80%
The time it takes for the the T4 to T1 ratio to reach 80%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
Time frame: after surgery, from the reappearance of T3 after Zemuron(R) (rocuronium) infusion/last bolus dose of Zemuron(R) (rocuronium)
Duration of Recovery of T4/T1 (TOF Fourth Twitch to First Twitch) Ratio 90%
The time it takes for the the T4 to T1 ratio to reach 90%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
Time frame: after surgery, from the reappearance of T3 after Zemuron(R) (rocuronium) infusion/last bolus dose of Zemuron(R) (rocuronium)
| Milestone | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) |
|---|---|---|---|---|---|---|---|---|---|---|
| Started | 5 | 8 | 18 | 21 | 19 | 7 | 6 | 20 | 25 | 20 |
| Completed | 4 | 6 | 18 | 18 | 17 | 5 | 6 | 19 | 22 | 18 |
| Not completed | 1 | 2 | 0 | 3 | 2 | 2 | 0 | 1 | 3 | 2 |
Total dose from administration of intubating dose to reappearance of T3 (the third twitch of a Train of Four \[TOF\] stimulation) after the last maintenance bolus dose or discontinuation of Zemuron (rocuronium) infusion (Per protocol \[PP\] data set)
| mg/kg | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Dose of Zemuron (Rocuronium) Administered | 0.91 ± 0.17 | 0.78 ± 0.07 | 0.86 ± 0.18 | 0.81 ± 0.10 | 0.96 ± 0.16 | 1.01 ± 0.37 | 0.84 ± 0.15 | 1.00 ± 0.25 | 1.26 ± 0.78 | 0.99 ± 0.37 |
The time it takes for the the T4 to T1 ratio to reach 70%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
| minutes | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) |
|---|---|---|---|---|---|---|---|---|---|---|
| Duration of Recovery of T4/T1 Ratio (TOF Fourth Twitch to First Twitch) 70% | 29.62 ± 13.60 | 33.25 ± 16.17 | 22.65 ± 7.62 | 16.19 ± 6.70 | 28.04 ± 13.33 | 43.32 ± 1.53 | 33.25 ± 0.00 | 23.08 ± 13.40 | 18.37 ± 12.69 | 27.59 ± 12.51 |
The time it takes for the the T4 to T1 ratio to reach 80%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
| minutes | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) |
|---|---|---|---|---|---|---|---|---|---|---|
| Duration of Recovery of T4/T1 (TOF Fourth Twitch to First Twitch) Ratio 80% | 36.62 ± 17.14 | 43.58 ± 21.47 | 32.39 ± 12.84 | 20.43 ± 9.79 | 35.75 ± 19.43 | 57.83 ± 12.33 | 44.75 ± 0.00 | 29.47 ± 16.65 | 21.82 ± 14.57 | 35.45 ± 17.02 |
The time it takes for the the T4 to T1 ratio to reach 90%. The T4/T1 ratio is indicative of recovery. At complete recovery, the T4/T1 ratio is 1.0 (100%).
| minutes | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) |
|---|---|---|---|---|---|---|---|---|---|---|
| Duration of Recovery of T4/T1 (TOF Fourth Twitch to First Twitch) Ratio 90% | 28.25 ± 0 | 53.66 ± 14.58 | 45.31 ± 18.20 | 23.09 ± 10.90 | 49.25 ± 31.73 | 52.25 ± 0 | 50.75 ± 0 | 37.86 ± 18.46 | 28.02 ± 21.46 | 38.68 ± 16.08 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Rocuronium Bolus Maintenance | — | 1/64 (1.6%) | 10/64 (15.6%) |
| Rocuronium Continuous Infusion Maintenance | — | 0/73 (0%) | 9/73 (12.3%) |
| Event | Rocuronium Bolus Maintenance | Rocuronium Continuous Infusion Maintenance |
|---|---|---|
| postoperative wound infectionInfections and infestations | 1/64 | 0/73 |
| Event | Rocuronium Bolus Maintenance | Rocuronium Continuous Infusion Maintenance |
|---|---|---|
| procedural painInjury, poisoning and procedural complications | 10/64 | 9/73 |
| Age, Categorical(Participants) | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| <=18 years | 5 | 6 | 18 | 18 | 17 | 5 | 6 | 19 | 23 | 20 | 137 |
| Between 18 and 65 years | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Rocuronium Bolus Maintenance - Neonate (BN) | Rocuronium Bolus Maintenance - Infants (BI) | Rocuronium Bolus Maintenance - Toddlers (BT) | Rocuronium Bolus Maintenance -Children (BC) | Rocuronium Bolus Maintenance - Adolescents (BA) | Rocuronium Continuous Infusion Maintenance - Neonates (IN) | Rocuronium Continuous Infusion Maintenance - Infants (II) | Rocuronium Continuous Infusion Maintenance - Toddlers (IT) | Rocuronium Continuous Infusion Maintenance - Children (IC) | Rocuronium Continuous Infusion Maintenance - Adolescents (IA) | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 2 | 1 | 1 | 8 | 6 | 2 | 3 | 6 | 11 | 12 | 52 |
| Male | 3 | 5 | 17 | 10 | 11 | 3 | 3 | 13 | 12 | 8 | 85 |
No study locations are listed for this record.
The record gives a start of Oct 2004, a primary completion of Aug 2007 and a completion of Sep 2007. It does not say whether these dates are actual or estimated.
Results were first posted in Apr 2009, 1 year 8 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Rocuronium